Recommend a female fertility topic for oration in Indian national fee conference who does routine icsi, FET cycle in 2 tier city
female fertility ICSI FET cycle outcomes optimization current trends
frozen embryo transfer endometrial preparation protocols ERA receptivity
This topic is perfectly positioned for a national audience. The freeze-all strategy has swept Indian IVF, but RCT data (including the FRESH trial and others) shows no universal benefit for normoresponders. A tier-2 practitioner questioning dogma from her own practice data makes a compelling, evidence-based oration. Covers endometrial receptivity, OHSS risk, cost burden on patients, and progesterone rise triggers.
| # | Topic | Why It Works |
|---|---|---|
| 1 | Progesterone on the day of trigger in GnRH antagonist ICSI cycles — should it change your decision? | Hot debate; directly changes daily clinical decisions; data from Venetis, ESHR 2024 meta-analyses |
| 2 | Endometrial receptivity testing (ERA) in FET cycles — evidence vs. commerce in Indian practice | Hugely relevant; ERA is heavily marketed in India; IGENOMIX data vs. RCT data; audience will engage |
| 3 | Optimal endometrial preparation for FET — Natural cycle vs. HRT vs. modified natural: Which protocol deserves your default? | Core FET topic, evolving evidence, suits tier-2 (no advanced lab tools needed) |
| 4 | PCOS and IVF — GnRH agonist trigger + freeze-all: Has it become our ethical obligation? | High PCOS prevalence in India; OHSS prevention is tier-2 relevant; strong ethical + evidence angle |
| 5 | Recurrent implantation failure (RIF) — Stripping away the myths: What actually works? | Always a conference favourite; covers endometrial scratching, PRP, hysteroscopy, thrombophilia workup — separating signal from noise |
| 6 | Poor ovarian response — Is POSEIDON changing how we counsel and treat in routine Indian practice? | POSEIDON classification is now mainstream; links to ICSI outcomes, donor egg counselling, personalised stimulation |
| 7 | Luteal phase support in FET cycles — Vaginal vs. oral vs. subcutaneous progesterone: Does the route matter? | Practical, evidence-based, cost-sensitive (tier-2 angle), recent RCT data available |
| 8 | The forgotten uterus in IVF — When to do hysteroscopy before ICSI/FET and when not to | Hysteroscopy overuse is a real issue in India; gives a balanced, guideline-driven oration |